DK148292D0 - Forbindelser - Google Patents

Forbindelser

Info

Publication number
DK148292D0
DK148292D0 DK921482A DK148292A DK148292D0 DK 148292 D0 DK148292 D0 DK 148292D0 DK 921482 A DK921482 A DK 921482A DK 148292 A DK148292 A DK 148292A DK 148292 D0 DK148292 D0 DK 148292D0
Authority
DK
Denmark
Prior art keywords
alkyl
alk
cyclo
aralkyl
relations
Prior art date
Application number
DK921482A
Other languages
English (en)
Inventor
Jens Kristian Perregaard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority to DK921482A priority Critical patent/DK148292D0/da
Publication of DK148292D0 publication Critical patent/DK148292D0/da
Priority to IL10780593A priority patent/IL107805A0/xx
Priority to ES94900792T priority patent/ES2119991T3/es
Priority to CA002151377A priority patent/CA2151377C/en
Priority to JP51369094A priority patent/JP3731827B2/ja
Priority to KR1019950702357A priority patent/KR100357976B1/ko
Priority to AT94900792T priority patent/ATE170168T1/de
Priority to DK94900792T priority patent/DK0673360T3/da
Priority to PCT/DK1993/000413 priority patent/WO1994013620A1/en
Priority to SG1996008150A priority patent/SG48233A1/en
Priority to AU55617/94A priority patent/AU675262B2/en
Priority to EP94900792A priority patent/EP0673360B1/en
Priority to CZ19951518A priority patent/CZ289820B6/cs
Priority to ZA939204A priority patent/ZA939204B/xx
Priority to DE69320652T priority patent/DE69320652T2/de
Priority to RU95116287A priority patent/RU2141474C1/ru
Priority to SK762-95A priority patent/SK281014B6/sk
Priority to HU9501669A priority patent/HU225111B1/hu
Priority to NZ258116A priority patent/NZ258116A/en
Priority to US08/504,847 priority patent/US5807889A/en
Priority to NO952274A priority patent/NO304686B1/no
Priority to FI952823A priority patent/FI114464B/fi
Priority to US08/955,376 priority patent/US5972964A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/57—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton
    • C07C211/60—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton containing a ring other than a six-membered aromatic ring forming part of at least one of the condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/80—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Detergent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
DK921482A 1992-12-09 1992-12-09 Forbindelser DK148292D0 (da)

Priority Applications (23)

Application Number Priority Date Filing Date Title
DK921482A DK148292D0 (da) 1992-12-09 1992-12-09 Forbindelser
IL10780593A IL107805A0 (en) 1992-12-09 1993-11-30 Aminomethylindans -benzofuranes and -benzothiophenes
NZ258116A NZ258116A (en) 1992-12-09 1993-12-08 5-amino-3-aminomethyl-indan, -benzofuran, and -benzothiophene derivatives; pharmaceutical compositions
AU55617/94A AU675262B2 (en) 1992-12-09 1993-12-08 Aminomethylindans, -benzofuranes and -benzothiophenes
ZA939204A ZA939204B (en) 1992-12-09 1993-12-08 Aminomethylindans,-benzofuranes and -benzothiophenes
JP51369094A JP3731827B2 (ja) 1992-12-09 1993-12-08 アミノメチルインダン、‐ベンゾフラン及び‐ベンゾチオフエン
KR1019950702357A KR100357976B1 (ko) 1992-12-09 1993-12-08 아미노메틸인단, -벤조푸란 및 -벤조티오펜
AT94900792T ATE170168T1 (de) 1992-12-09 1993-12-08 Aminomethylindane,-benzofurane und benzothiopene
DK94900792T DK0673360T3 (da) 1992-12-09 1993-12-08 Aminomethylindaner, -benzofuraner og -benzothiophener
PCT/DK1993/000413 WO1994013620A1 (en) 1992-12-09 1993-12-08 Aminomethylindans, -benzofuranes and -benzothiophenes
SG1996008150A SG48233A1 (en) 1992-12-09 1993-12-08 Aminomethylindans - benzofuranes and - benzothiophenes
ES94900792T ES2119991T3 (es) 1992-12-09 1993-12-08 Aminometil-indanos, -benzofuranos y -benzotiofenos.
EP94900792A EP0673360B1 (en) 1992-12-09 1993-12-08 Aminomethylindans, -benzofuranes and -benzothiophenes
CZ19951518A CZ289820B6 (cs) 1992-12-09 1993-12-08 Aminomethyl-indany, -benzofurany a -benzothiofeny, jejich pouľití a farmaceutický prostředek
CA002151377A CA2151377C (en) 1992-12-09 1993-12-08 Aminomethylindans, -benzofurans and -benzothiophenes
DE69320652T DE69320652T2 (de) 1992-12-09 1993-12-08 Aminomethylindane,-benzofurane und benzothiopene
RU95116287A RU2141474C1 (ru) 1992-12-09 1993-12-08 Аминометилинданы - бензофураны и бензотиофены
SK762-95A SK281014B6 (sk) 1992-12-09 1993-12-08 Aminometylindány, -benzofurány a -benzotiofény, ich použitie a farmaceutická zmes s ich obsahom
HU9501669A HU225111B1 (en) 1992-12-09 1993-12-08 Aminomethylindans, -benzofuranes and-benzothiophenes and pharmaceutical compositions containing them
US08/504,847 US5807889A (en) 1992-12-09 1995-06-06 Aminomethylindans, -benzofuranes and -benzothiophenes
NO952274A NO304686B1 (no) 1992-12-09 1995-06-08 Aminometylindaner, -benzofuraner og -benzotiofener
FI952823A FI114464B (fi) 1992-12-09 1995-06-08 Menetelmä uusien terapeuttisesti käyttökelpoisten aminometyyli-indaani-, -bentsofuraani ja -bentsotiofeenijohdannaisten valmistamiseksi
US08/955,376 US5972964A (en) 1992-12-09 1997-10-22 Aminomethylindans, -benzofurans and -benzothiophenes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK921482A DK148292D0 (da) 1992-12-09 1992-12-09 Forbindelser

Publications (1)

Publication Number Publication Date
DK148292D0 true DK148292D0 (da) 1992-12-09

Family

ID=8105305

Family Applications (2)

Application Number Title Priority Date Filing Date
DK921482A DK148292D0 (da) 1992-12-09 1992-12-09 Forbindelser
DK94900792T DK0673360T3 (da) 1992-12-09 1993-12-08 Aminomethylindaner, -benzofuraner og -benzothiophener

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK94900792T DK0673360T3 (da) 1992-12-09 1993-12-08 Aminomethylindaner, -benzofuraner og -benzothiophener

Country Status (21)

Country Link
US (2) US5807889A (da)
EP (1) EP0673360B1 (da)
JP (1) JP3731827B2 (da)
KR (1) KR100357976B1 (da)
AT (1) ATE170168T1 (da)
AU (1) AU675262B2 (da)
CA (1) CA2151377C (da)
CZ (1) CZ289820B6 (da)
DE (1) DE69320652T2 (da)
DK (2) DK148292D0 (da)
ES (1) ES2119991T3 (da)
FI (1) FI114464B (da)
HU (1) HU225111B1 (da)
IL (1) IL107805A0 (da)
NO (1) NO304686B1 (da)
NZ (1) NZ258116A (da)
RU (1) RU2141474C1 (da)
SG (1) SG48233A1 (da)
SK (1) SK281014B6 (da)
WO (1) WO1994013620A1 (da)
ZA (1) ZA939204B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9614347D0 (en) * 1996-07-09 1996-09-04 Smithkline Beecham Spa Novel compounds
FR2752839B1 (fr) * 1996-08-29 1998-10-09 Synthelabo Derives de benzofurane, leur preparation et leur application en therapeutique
DE19642451A1 (de) * 1996-10-15 1998-04-16 Merck Patent Gmbh Aminothiophencarbonsäureamide
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
SE9904674D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
AR032641A1 (es) * 2001-01-29 2003-11-19 Otsuka Pharma Co Ltd Agonista de subtipo de receptor 5-ht 1a.
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
US8703772B2 (en) 2001-09-25 2014-04-22 Otsuka Pharmaceutical Co., Ltd. Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
TW200524915A (en) * 2003-09-26 2005-08-01 Tanabe Seiyaku Co Carbamoyl-type benzofuran derivatives
RU2402549C3 (ru) * 2005-04-14 2022-03-10 Оцука Фармасьютикал Ко., Лтд. Пиперазин-замещенные бензотиофены для лечения психических расстройств
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2006133339A2 (en) * 2005-06-07 2006-12-14 Neurocrine Biosciences, Inc. Monoamine re-uptake inhibitors and methods relating thereto
TWI329641B (en) * 2005-08-31 2010-09-01 Otsuka Pharma Co Ltd (benzo[b]thiophen-4-yl)piperazine compounds, pharmaceutical compositions comprising the same, uses of the same and processes for preparing the same
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
CN101434552B (zh) * 2007-11-16 2012-05-23 江苏恒瑞医药股份有限公司 4,5-二甲氧基-1-(甲基氨基甲基)-苯并环丁烷的拆分
RU2393855C1 (ru) * 2008-12-29 2010-07-10 Общество С Ограниченной Ответственностью "Валента-Интеллект" Средство, обладающее анксиолитической и церебропротекторной активностью, уменьшающее влечение к алкоголю
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN112399860B (zh) 2018-06-06 2024-08-16 麻省理工学院 用于在真核细胞中翻译的环状rna
EP3972653A1 (en) 2019-05-22 2022-03-30 Massachusetts Institute of Technology Circular rna compositions and methods
CN115052635B (zh) 2019-12-04 2025-07-22 奥纳治疗公司 环状rna组合物和方法
US12297285B2 (en) 2022-06-24 2025-05-13 Orna Therapeutics, Inc. Circular RNA encoding chimeric antigen receptors targeting BCMA

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2322470A1 (de) * 1973-05-04 1974-11-21 Boehringer Sohn Ingelheim Neue indolyl-piperidino-(bzw. 1,2,5,6tetrahydro-pyridyl-)butyrophenone und verfahren zu ihrer herstellung
FR2391211A2 (fr) * 1977-05-18 1978-12-15 Roussel Uclaf Nouveaux derives de 2,3-dihydroa(4-(3-indolyl) 1-piperidinyl) methyl 1,4-benzodioxin-2-methanol, un procede de preparation, et leur application comme medicaments
DE2827874A1 (de) * 1978-06-24 1980-02-07 Merck Patent Gmbh Indolalkylamine und verfahren zu ihrer herstellung
GB2093837B (en) * 1981-03-02 1985-04-24 Abbott Lab Aminoalkyl subsituted 1,2,3,4-tetrahydronaphtalenes
US4500543A (en) * 1982-06-01 1985-02-19 Abbott Laboratories Substituted 1-aminomethyl-phthalans
FR2533924A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives du 4-(1h-indol-3-yl)a-methyl piperidine-1-ethanol, leurs sels, le procede de preparation, l'application a titre de medicaments et les compositions les renfermant
US4670447A (en) * 1983-08-22 1987-06-02 Hoechst-Roussel Pharmaceuticals Inc. Antipsychotic 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
EP0231261B1 (en) * 1985-07-05 1994-04-06 The Liposome Company, Inc. Multilamellar liposomes having improved trapping efficiencies
GB8610909D0 (en) * 1986-05-03 1986-06-11 Beecham Group Plc Compounds
GB8704572D0 (en) * 1987-02-26 1987-04-01 Lundbeck & Co As H Organic compounds
GB8707122D0 (en) * 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents
US5561152A (en) * 1987-08-14 1996-10-01 Merrell Pharmaceuticals Inc. Antidepressants
EP0325963B1 (en) * 1988-01-15 1993-09-22 Abbott Laboratories 1-aminomethyl-1,2,3,4-tetrahydronaphthalenes and -indanes
GB8820651D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
US5225596A (en) * 1989-01-09 1993-07-06 The Upjohn Company Halo substituted aminotetralins
DE3919624A1 (de) * 1989-06-15 1990-12-20 Boehringer Ingelheim Kg Neue 2,5-diaminotetraline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3924365A1 (de) * 1989-07-22 1991-01-24 Boehringer Ingelheim Kg 2-amino-7-carbamoyl-1,2,3,4- tetrahydronaphthaline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DK152090D0 (da) * 1990-06-22 1990-06-22 Lundbaek A S H Piperidylsubstituerede indolderivater

Also Published As

Publication number Publication date
HUT73633A (en) 1996-08-28
EP0673360A1 (en) 1995-09-27
WO1994013620A1 (en) 1994-06-23
JP3731827B2 (ja) 2006-01-05
CZ289820B6 (cs) 2002-04-17
SG48233A1 (en) 1998-04-17
AU5561794A (en) 1994-07-04
DK0673360T3 (da) 1999-05-25
HU225111B1 (en) 2006-06-28
JPH08504409A (ja) 1996-05-14
DE69320652D1 (de) 1998-10-01
NZ258116A (en) 1996-06-25
CZ151895A3 (en) 1996-03-13
ES2119991T3 (es) 1998-10-16
ATE170168T1 (de) 1998-09-15
NO304686B1 (no) 1999-02-01
RU2141474C1 (ru) 1999-11-20
CA2151377C (en) 2005-07-05
SK76295A3 (en) 1996-02-07
KR950704234A (ko) 1995-11-17
AU675262B2 (en) 1997-01-30
EP0673360B1 (en) 1998-08-26
FI114464B (fi) 2004-10-29
US5807889A (en) 1998-09-15
HU9501669D0 (en) 1996-05-28
RU95116287A (ru) 1997-06-10
KR100357976B1 (ko) 2003-01-24
IL107805A0 (en) 1994-02-27
FI952823A7 (fi) 1995-06-08
US5972964A (en) 1999-10-26
NO952274L (no) 1995-08-02
CA2151377A1 (en) 1994-06-23
FI952823A0 (fi) 1995-06-08
DE69320652T2 (de) 1999-04-01
ZA939204B (en) 1994-08-08
NO952274D0 (no) 1995-06-08
SK281014B6 (sk) 2000-10-09

Similar Documents

Publication Publication Date Title
DK148292D0 (da) Forbindelser
ATE175966T1 (de) Ace-hemmer die ein kondensiertes polycyclisches- lactam enthalten
ES2077591T3 (es) Derivados de acido (met)acrilico opticamente activos, su fabricacion, su polimerizacion para dar polimeros opticamente activos y su uso.
DE69020162D1 (de) Synthese und verwendung von aminosäurefluoriden als peptidkopplungsreagentien.
EP0991651A4 (en) STABILIZED CARBAPENEM INTERMEDIATE PRODUCTS AND THEIR USE IN SYNTHESIS
DE69425176D1 (de) Verfahren zur Herstellung von Alkylimidazolidone Acrylate
TW238304B (en) A process for the preparation of 1-substituted-5(4H)-tetrazolinones
GB1332195A (en) Polymers of acrylic ester compounds
GR3033965T3 (en) Boric ester synthesis.
ES8707549A1 (es) Un procedimiento para preparar compuestos peptidicos sustituidos
RU95102102A (ru) Nальфа -2(4-НИТРОФЕНИЛСУЛЬФОНИЛ)ЭТОКСИКАРБОНИЛ-АМИНОКИСЛОТЫ
ES2109016T3 (es) Procedimiento para la obtencion de triazinas asimetricamente substituidas.
GB1192862A (en) Alkoxymethylamide Derivatives of Esters and/or Amides of Acids of Phosphorus
ATE38984T1 (de) Isocyanato-azetidin-dionen.
KR830004203A (ko) 2-아미노 에탄올 유도체의 제조방법
GB1142330A (en) Process for the preparation of polymers containing urethaneor urea methylol alkyl oralkenyl ether groups
GB1480908A (en) Carbamates of carbocyclic fused 2-hydroxy-substituted tetrahydrofuran-ones and their use as pharmaceuticals
DE3879622D1 (de) Aminopimelinsaeure-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel.
YU48893A (sh) Postupak za sintezu 17 alfa-metil-17-propionilestra-4,9-dien-3-ona
GB1251525A (da)
ES8600762A1 (es) Un procedimiento para la preparacion de nuevos compuestos de beta-lactama.
JPS5461163A (en) Novel compound
SE8207478D0 (sv) New bicyclic compounds and a process for the preparation thereof
YU127289A (sh) INHIBITORI 5-OKSIGENISANE HMG-CoA REDUKTAZE
SE8207474D0 (sv) New heterocyclic carboxylic acids and a process for the preparation thereof

Legal Events

Date Code Title Description
A0 Application filed
AHS Application shelved for other reasons than non-payment
PUP Patent expired